SEC Form 4 · accession 0001385213-17-000004
Sanara MedTech Inc. · SMTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Christopher Siedhoff
Director
Period of report
Feb 20, 2015
Accepted (ET)
Apr 5, 2017 · 8:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000714256
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 20, 2015 | C | 750,000 | — | A | 7,000,000 | D | |
| Common Stock | Feb 27, 2017 | A | 150,000 | $0.00 | A | 7,150,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series D Preferred StockF1 | — | Feb 20, 2015 | C | 750 | D | — | — | Common Stock | 750,000 | 0 | D |
Explanation of responses
- F1The Series D Preferred Stock was convertible on a 1,000-for-1 basis, into shares of the issuer's common stock, upon the issuer's charter being amended to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000. The issuer's charter was amended to reflect such increase in the number of authorized shares of common stock effective February 20, 2015.